Diagnostic yield of a risk model versus faecal immunochemical test only: a randomised controlled trial in a colorectal cancer screening programme

Tim L. Kortlever; Manon van der Vlugt; Floor A.M. Duijkers; Ad Masclee; Roderik Kraaijenhagen; Manon C.W. Spaander; Iris Lansdorp-Vogelaar; Patrick M. Bossuyt; Evelien Dekker

doi:10.1038/s41416-023-02358-z

Diagnostic yield of a risk model versus faecal immunochemical test only: a randomised controlled trial in a colorectal cancer screening programme

Tim L. Kortlever, Manon van der Vlugt, Floor A.M. Duijkers, Ad Masclee, Roderik Kraaijenhagen, Manon C.W. Spaander, Iris Lansdorp-Vogelaar, Patrick M. Bossuyt, Evelien Dekker^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

2 Citations (Scopus)

Abstract

Background:

Combining the faecal immunochemical test (FIT) result with risk factors for advanced neoplasia (AN) may increase the yield of colorectal cancer (CRC) screening without increasing the number of colonoscopies. We conducted a randomised controlled trial in the Dutch CRC screening programme to evaluate a previously developed risk model including FIT, age, sex, smoking status, and CRC family history.

Methods:

A total of 22,748 individuals aged 56–75 years were pre-randomised to the risk-model group or the FIT-only group. Both groups received the FIT; those allocated to the risk-model group also received a single-page questionnaire. Study participants with a positive result (FIT ≥ 15 µg Hb/g faeces and/or risk ≥0.10) were referred for colonoscopy. The primary outcome measure was the proportion of invitees in whom AN was detected.

Results:

In the risk-model group, 3113/11,364 invitees (27%) returned the FIT and questionnaire versus 3061/11,384 invitees (27%) in the FIT-only group (p = 0.40). The yield of AN was 3.70/1000 invitees in the risk-model group versus 3.43/1000 in the FIT-only group (absolute difference: 0.27/1000, 95%CI: −1.30 to 1.82, p = 0.82).

Conclusions:

Combining FIT with risk factors for CRC did not increase the yield of AN compared to FIT-only in an existing CRC screening programme. There was no difference in participation between groups. Clinical trial registration: NCT04490551 (ClinicalTrials.gov).

Original language	English
Pages (from-to)	791-796
Number of pages	6
Journal	British Journal of Cancer
Volume	129
Issue number	5
Early online date	19 Jul 2023
DOIs	https://doi.org/10.1038/s41416-023-02358-z
Publication status	Published - 21 Sept 2023

Bibliographical note

Funding Information:
This study was supported by the Netherlands Organisation for Health Research and Development (ZonMw). ZonMw had no role in the study design; data collection, analysis, or interpretation; in the writing of the report, and in the decision to submit the paper for publication.

Funding Information:
AM received financial support from Pentax Europe. MS received material and financial support from Sentinel, Sysmex, and Medtronic. ED received endoscopic equipment on loan from FujiFilm and Olympus, received a research grant from FujiFilm, received honorarium for consultancy from FujiFilm, Olympus, GI Supply, CPP-FAP, PAION, and Ambu, and speakers’ fees from Olympus, GI Supply, Norgine, IPSEN, PAION, and FujiFilm. The remaining authors disclose no conflicts.

Publisher Copyright:
© 2023, The Author(s), under exclusive licence to Springer Nature Limited.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/s41416-023-02358-z

Cite this

Kortlever, T. L., van der Vlugt, M., Duijkers, F. A. M., Masclee, A., Kraaijenhagen, R., Spaander, M. C. W., Lansdorp-Vogelaar, I., Bossuyt, P. M., & Dekker, E. (2023). Diagnostic yield of a risk model versus faecal immunochemical test only: a randomised controlled trial in a colorectal cancer screening programme. British Journal of Cancer, 129(5), 791-796. https://doi.org/10.1038/s41416-023-02358-z

@article{ffb789bfb02c4c13a282f935f3c47f73,

title = "Diagnostic yield of a risk model versus faecal immunochemical test only: a randomised controlled trial in a colorectal cancer screening programme",

abstract = "Background:Combining the faecal immunochemical test (FIT) result with risk factors for advanced neoplasia (AN) may increase the yield of colorectal cancer (CRC) screening without increasing the number of colonoscopies. We conducted a randomised controlled trial in the Dutch CRC screening programme to evaluate a previously developed risk model including FIT, age, sex, smoking status, and CRC family history. Methods: A total of 22,748 individuals aged 56–75 years were pre-randomised to the risk-model group or the FIT-only group. Both groups received the FIT; those allocated to the risk-model group also received a single-page questionnaire. Study participants with a positive result (FIT ≥ 15 µg Hb/g faeces and/or risk ≥0.10) were referred for colonoscopy. The primary outcome measure was the proportion of invitees in whom AN was detected. Results: In the risk-model group, 3113/11,364 invitees (27%) returned the FIT and questionnaire versus 3061/11,384 invitees (27%) in the FIT-only group (p = 0.40). The yield of AN was 3.70/1000 invitees in the risk-model group versus 3.43/1000 in the FIT-only group (absolute difference: 0.27/1000, 95%CI: −1.30 to 1.82, p = 0.82). Conclusions:Combining FIT with risk factors for CRC did not increase the yield of AN compared to FIT-only in an existing CRC screening programme. There was no difference in participation between groups. Clinical trial registration: NCT04490551 (ClinicalTrials.gov).",

author = "Kortlever, {Tim L.} and {van der Vlugt}, Manon and Duijkers, {Floor A.M.} and Ad Masclee and Roderik Kraaijenhagen and Spaander, {Manon C.W.} and Iris Lansdorp-Vogelaar and Bossuyt, {Patrick M.} and Evelien Dekker",

note = "Funding Information: This study was supported by the Netherlands Organisation for Health Research and Development (ZonMw). ZonMw had no role in the study design; data collection, analysis, or interpretation; in the writing of the report, and in the decision to submit the paper for publication. Funding Information: AM received financial support from Pentax Europe. MS received material and financial support from Sentinel, Sysmex, and Medtronic. ED received endoscopic equipment on loan from FujiFilm and Olympus, received a research grant from FujiFilm, received honorarium for consultancy from FujiFilm, Olympus, GI Supply, CPP-FAP, PAION, and Ambu, and speakers{\textquoteright} fees from Olympus, GI Supply, Norgine, IPSEN, PAION, and FujiFilm. The remaining authors disclose no conflicts. Publisher Copyright: {\textcopyright} 2023, The Author(s), under exclusive licence to Springer Nature Limited.",

year = "2023",

month = sep,

day = "21",

doi = "10.1038/s41416-023-02358-z",

language = "English",

volume = "129",

pages = "791--796",

journal = "British Journal of Cancer",

issn = "0007-0920",

publisher = "Springer Nature",

number = "5",

}

Kortlever, TL, van der Vlugt, M, Duijkers, FAM, Masclee, A, Kraaijenhagen, R, Spaander, MCW , Lansdorp-Vogelaar, I, Bossuyt, PM & Dekker, E 2023, 'Diagnostic yield of a risk model versus faecal immunochemical test only: a randomised controlled trial in a colorectal cancer screening programme', British Journal of Cancer, vol. 129, no. 5, pp. 791-796. https://doi.org/10.1038/s41416-023-02358-z

Diagnostic yield of a risk model versus faecal immunochemical test only: a randomised controlled trial in a colorectal cancer screening programme. / Kortlever, Tim L.; van der Vlugt, Manon; Duijkers, Floor A.M. et al.
In: British Journal of Cancer, Vol. 129, No. 5, 21.09.2023, p. 791-796.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Diagnostic yield of a risk model versus faecal immunochemical test only

T2 - a randomised controlled trial in a colorectal cancer screening programme

AU - Kortlever, Tim L.

AU - van der Vlugt, Manon

AU - Duijkers, Floor A.M.

AU - Masclee, Ad

AU - Kraaijenhagen, Roderik

AU - Spaander, Manon C.W.

AU - Lansdorp-Vogelaar, Iris

AU - Bossuyt, Patrick M.

AU - Dekker, Evelien

N1 - Funding Information: This study was supported by the Netherlands Organisation for Health Research and Development (ZonMw). ZonMw had no role in the study design; data collection, analysis, or interpretation; in the writing of the report, and in the decision to submit the paper for publication. Funding Information: AM received financial support from Pentax Europe. MS received material and financial support from Sentinel, Sysmex, and Medtronic. ED received endoscopic equipment on loan from FujiFilm and Olympus, received a research grant from FujiFilm, received honorarium for consultancy from FujiFilm, Olympus, GI Supply, CPP-FAP, PAION, and Ambu, and speakers’ fees from Olympus, GI Supply, Norgine, IPSEN, PAION, and FujiFilm. The remaining authors disclose no conflicts. Publisher Copyright: © 2023, The Author(s), under exclusive licence to Springer Nature Limited.

PY - 2023/9/21

Y1 - 2023/9/21

N2 - Background:Combining the faecal immunochemical test (FIT) result with risk factors for advanced neoplasia (AN) may increase the yield of colorectal cancer (CRC) screening without increasing the number of colonoscopies. We conducted a randomised controlled trial in the Dutch CRC screening programme to evaluate a previously developed risk model including FIT, age, sex, smoking status, and CRC family history. Methods: A total of 22,748 individuals aged 56–75 years were pre-randomised to the risk-model group or the FIT-only group. Both groups received the FIT; those allocated to the risk-model group also received a single-page questionnaire. Study participants with a positive result (FIT ≥ 15 µg Hb/g faeces and/or risk ≥0.10) were referred for colonoscopy. The primary outcome measure was the proportion of invitees in whom AN was detected. Results: In the risk-model group, 3113/11,364 invitees (27%) returned the FIT and questionnaire versus 3061/11,384 invitees (27%) in the FIT-only group (p = 0.40). The yield of AN was 3.70/1000 invitees in the risk-model group versus 3.43/1000 in the FIT-only group (absolute difference: 0.27/1000, 95%CI: −1.30 to 1.82, p = 0.82). Conclusions:Combining FIT with risk factors for CRC did not increase the yield of AN compared to FIT-only in an existing CRC screening programme. There was no difference in participation between groups. Clinical trial registration: NCT04490551 (ClinicalTrials.gov).

AB - Background:Combining the faecal immunochemical test (FIT) result with risk factors for advanced neoplasia (AN) may increase the yield of colorectal cancer (CRC) screening without increasing the number of colonoscopies. We conducted a randomised controlled trial in the Dutch CRC screening programme to evaluate a previously developed risk model including FIT, age, sex, smoking status, and CRC family history. Methods: A total of 22,748 individuals aged 56–75 years were pre-randomised to the risk-model group or the FIT-only group. Both groups received the FIT; those allocated to the risk-model group also received a single-page questionnaire. Study participants with a positive result (FIT ≥ 15 µg Hb/g faeces and/or risk ≥0.10) were referred for colonoscopy. The primary outcome measure was the proportion of invitees in whom AN was detected. Results: In the risk-model group, 3113/11,364 invitees (27%) returned the FIT and questionnaire versus 3061/11,384 invitees (27%) in the FIT-only group (p = 0.40). The yield of AN was 3.70/1000 invitees in the risk-model group versus 3.43/1000 in the FIT-only group (absolute difference: 0.27/1000, 95%CI: −1.30 to 1.82, p = 0.82). Conclusions:Combining FIT with risk factors for CRC did not increase the yield of AN compared to FIT-only in an existing CRC screening programme. There was no difference in participation between groups. Clinical trial registration: NCT04490551 (ClinicalTrials.gov).

UR - http://www.scopus.com/inward/record.url?scp=85165142665&partnerID=8YFLogxK

U2 - 10.1038/s41416-023-02358-z

DO - 10.1038/s41416-023-02358-z

M3 - Article

C2 - 37468570

AN - SCOPUS:85165142665

SN - 0007-0920

VL - 129

SP - 791

EP - 796

JO - British Journal of Cancer

JF - British Journal of Cancer

IS - 5

ER -

Diagnostic yield of a risk model versus faecal immunochemical test only: a randomised controlled trial in a colorectal cancer screening programme

Abstract

Bibliographical note

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this